| Market Cap | ₹88,218Cr |
| ROE | 19.08% |
| P/E Ratio(TTM) | 23.70 |
| EPS(TTM) | 81.49 |
| P/B Ratio | 5.13 |
| Dividend Yield | 0.62% |
| Industry P/E | 34.91 |
| Book Value | 376.64 |
| Debt to Equity | 0.32 |
| Face Value | 2 |
| Parent Organisation | Lupin Limited |
| Managing Director | NA |
| NSE Symbol | LUPIN |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Sun Pharmaceutical Industries | NA (0.00%) | 39.22 | ||
| Cipla | NA (0.00%) | 23.76 | ||
| Dr Reddy's Laboratories | NA (0.00%) | 18.66 | ||
| Zydus Lifesciences | NA (0.00%) | 21.48 |